We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

Content type
Tags
Author
Jurisdiction

85 results found

Article

Lathrop Gage LLP | USA | 30 Aug 2011

CAFC upholds validity of formulation claim (Fortical)

On August 25, 2011, the Court of Appeals for the Federal Circuit (CAFC) upheld a District Court’s grant of summary judgment of non-obviousness with respect to a pharmaceutical composition comprising salmon calcitonin and a specific concentration of citric acid and other components.

Article

Hogan Lovells | France | 21 Jul 2011

Generic pharmaceutical companies can use original drug's trademarks if the comparative advertising is lawful

The French Supreme Court recently issued its long-awaited decision in the "Deroxat" case.

Article

Lathrop Gage LLP | USA | 6 Jul 2011

CAFC invalidates claims covering specified dose range as obvious

On June 22, 2011, the Court of Appeals for the Federal Circuit (CAFC) upheld a summary judgment invalidating two claims of U.S. Patent No. 5,211,954 (“the ‘954 patent”), which covers a pharmaceutical formulation comprising particular doses of a sleep-inducing agent.

Article

Piper Alderman | Australia | 7 Jun 2011

Regulation and PBS pricing of biosimilar drugs

In this article, we examine the issues surrounding the regulation of biosimilar drugs in Australia, including pricing issues under the Pharmaceutical Benefits Scheme.

Article

OLIVARES | Mexico | 2 Dec 2009

Repercussions expected on medicine advertising campaign

A bold new television advertising and publicity campaign was launched recently by a pharmaceutical company called Genoma Lab.

Article

Locke Lord LLP | USA | 20 Oct 2009

Infringement conflict for product-by process claims resolved

In a consolidated case on appeal from two separate jurisdictions, the Federal Circuit overruled an earlier decision to resolve a conflict regarding product-byprocess infringement claims.

Article

Gowling WLG | Canada | 21 Apr 2008

Bayer Healthcare v Sandoz; an appeal of judicial review of a decision of the Minister; January 23, 2008; drug: ciprofloxacin

Bayer challenged the Minister's decision to issue a NOC to Sandoz in respect of vials of ciprofloxacin.

Article

Gowling WLG | Canada | 7 Feb 2008

Bayer Healthcare v Sandoz; an appeal of judicial review of a decision of the minister; January 23, 2008; drug: ciprofloxacin

Bayer challenged the Minister's decision to issue a NOC to Sandoz in respect of vials of ciprofloxacin.

Previous page 1 2 3 ...